1. MUC1 antibody-based therapeutics: the promise of cancer immunotherapy
   Mona Pourjafar et al, 2020, Immunotherapy CrossRef
2. Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer
   Hanyi Fang et al, 2021, Frontiers in Pharmacology CrossRef
3. Electrochemical biotool for the dual determination of epithelial mucins associated to prognosis and minimal residual disease in colorectal cancer
   Sandra Tejerina-Miranda et al, 2023, International Journal of Biological Macromolecules CrossRef
4. Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers
   Jing Peng et al, 2023, Frontiers in Endocrinology CrossRef
5. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer
   Víctor J. Somovilla et al, 2017, Journal of the American Chemical Society CrossRef
6. Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers
   Mukulika Bose et al, 2020, Vaccines CrossRef